...
首页> 外文期刊>Medicine. >The number of retrieved lymph nodes needed for accurate staging differs based on the presence of preoperative chemoradiation for rectal cancer
【24h】

The number of retrieved lymph nodes needed for accurate staging differs based on the presence of preoperative chemoradiation for rectal cancer

机译:根据直肠癌术前放化疗的存在,准确分期所需的取出淋巴结数目会有所不同

获取原文
获取原文并翻译 | 示例

摘要

The aim of this study is to investigate if retrieval of 12 lymph nodes (LNs) is sufficient to avoid stage migration as well as to evaluate the prognostic impact of insufficient LN retrieval in different treatment settings of rectal cancer, particularly in the case of preoperative chemoradiotherapy (pCRT).The data of all patients with biopsy proven rectal adenocarcinoma who underwent curative surgery between January 2005 and December 2012 were analyzed. Univariate and multivariate analyses for oncologic outcomes were performed in LN metastasis or no LN metastasis (LN-) group. Subgroup analyses were performed according to whether a patient had received pCRT.A total of 1825 patients were enrolled into the study. The maximal Chi-square method revealed the minimum number of harvested LNs required to be 12. Univariate and multivariate analyses found LNs12 to be an independent prognostic factor for both overall survival (OS) (hazard ratio [HR] = 0.5, 95% confidence intervals [CIs]: 0.3-0.8; P = 0.002) and disease-free survival (DFS) (HR = 0.6, 95% CI: 0.4-0.7; P<0.001) in the LN- group. In the LN- group, LNs12 continued to be a significant prognostic factor both for OS and DFS in the subgroup of patients who did not undergo pCRT. However, in the subgroup of the LN- patients who underwent pCRT, LN8 was significant for DFS and OS.Retrieval of LNs12 and LNs8 should be achieved to obtain accurate staging and optimal treatment for the non-pCRT and pCRT groups in rectal cancer, respectively.
机译:这项研究的目的是调查12个淋巴结(LN)的回收是否足以避免分期迁移以及评估LN回收不足在直肠癌的不同治疗环境中对预后的影响,特别是在术前放化疗的情况下分析2005年1月至2012年12月期间接受根治性手术的所有活检证实为直肠腺癌的患者的数据。在LN转移或无LN转移(LN-)组中进行肿瘤结局的单因素和多因素分析。根据患者是否接受过pCRT进行亚组分析。总共1825名患者参加了研究。最大卡方方法显示需要采集的LN最少数量为12。单因素和多因素分析发现LNs12是整体生存(OS)的独立预后因素(危险比[HR] = 0.5,95%置信区间[NCI]:0.3-0.8; P = 0.002)和LN-组的无病生存期(DFS)(HR = 0.6,95%CI:0.4-0.7; P <0.001)。在LN组中,LNs12仍然是未接受pCRT的患者亚组OS和DFS的重要预后因素。然而,在接受pCRT的LN患者亚组中,LN8对于DFS和OS均具有重要意义。应该实现对LNs12和LNs8的检索,以分别获得正确的分期和针对非pCRT和pCRT组的直肠癌最佳治疗方案。 。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号